ADCT icon

ADC Therapeutics
ADCT

Overview Fund Activity

49 hedge funds and large institutions have $501M invested in ADC Therapeutics in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
-6
Holders Change %
-10.91%
% of All Funds
0.78%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
4
Increased
17
Reduced
11
Closed
10
Calls
$527K
Puts
$190K
Net Calls
+$337K
Net Calls Change
-$615K

Top Buyers

1
MCMC
Matrix Capital Management Company
New Hampshire
$5.88M
2
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
$50.2M
3
Walleye Capital
Walleye Capital
New York
$3.65M
4
AllianceBernstein
AllianceBernstein
Tennessee
$43.4M
5
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$952K

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$36.2M
2
Invesco
Invesco
Georgia
$0
3
Bank of America
Bank of America
North Carolina
$112K
4
Millennium Management
Millennium Management
New York
$0
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
UBS Group
51
UBS Group
Switzerland
– -$49K -2,426 Closed
Lazard Asset Management
52
Lazard Asset Management
New York
– -$37K -1,863 Closed
DFCM
53
Dark Forest Capital Management
Puerto Rico
– -$8K -387 Closed
Group One Trading
54
Group One Trading
Illinois
– -$2K -100 Closed
Simplex Trading
55
Simplex Trading
Illinois
– -$1K -89 Closed
TFA
56
Toth Financial Advisory
Virginia
– -$1K -70 Closed
1 2
3